Benefits of superficial hyperthermia treatment planning: five case studies
/in Breast Cancer, Hyperthermia, International Publications, Malignant Melanoma /von 2007-08-01 / Int J Hyperthermia 2007 Aug;23(5):417-29Intratumoral injection of dendritic cells in combination with local hyperthermia induces systemic antitumor effect in patients with advanced melanoma
/in Dendritic Cells, Hyperthermia, International Publications, Malignant Melanoma /von 2007-06-01 / Int. J. Cancer 2007 Jun;120(11):2418-25Melanoma-infiltrating dendritic cells induce protective antitumor responses mediated by T cells
/in International Publications, Malignant Melanoma /von 2007-06-01 / Melanoma Res. 2007 Jun;17(3):169-76Immunological response in the mouse melanoma model after local hyperthermia
/in Hyperthermia, International Publications, Malignant Melanoma /von 2007-05-30 / Physiol Res 2008;57(3):459-65Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+) T lymphocytes
/in International Publications, Malignant Melanoma /von 2007-04-20 / J Transl Med 2007 Apr;5:19Dendritic cell-based immunotherapy of malignant melanoma: success and limitations
/in International Publications, Malignant Melanoma /von 2007-03-01 / J Dtsch Dermatol Ges 2007 Mar;5(3):190-6Induction of dendritic cell-mediated immune responses against canine malignant melanoma cells
/in International Publications, Malignant Melanoma /von 2007-01-08 / Vet. J. 2008 Jan;175(1):126-9Lymphocyte subpopulations in melanoma patients treated with dendritic cell vaccines
/in International Publications, Malignant Melanoma /von 2007-01-01 / Adv. Exp. Med. Biol. 2007;601:381-6Results of a pilot trial of immunotherapy with dendritic cells pulsed with autologous tumor lysates in patients with advanced cancer
/in Breast Cancer, International Publications, Malignant Melanoma /von 2007-01-01 / Tumori 2007 Jan-Feb;93(1):26-30
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de